Farid Abrigach

897 total citations
39 papers, 753 citations indexed

About

Farid Abrigach is a scholar working on Organic Chemistry, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Farid Abrigach has authored 39 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 8 papers in Oncology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Farid Abrigach's work include Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (8 papers) and Multicomponent Synthesis of Heterocycles (7 papers). Farid Abrigach is often cited by papers focused on Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (8 papers) and Multicomponent Synthesis of Heterocycles (7 papers). Farid Abrigach collaborates with scholars based in Morocco, France and Saudi Arabia. Farid Abrigach's co-authors include Rachid Touzani, Yassine Kaddouri, Mohamed El Kodadi, B. Hammouti, Smaail Radi, Abdelilah Takfaoui, A. Zarrouk, A. El Assyry, Henri Doucet and A. Bouyanzer and has published in prestigious journals such as Molecules, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Farid Abrigach

37 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farid Abrigach Morocco 17 376 207 148 93 91 39 753
Aziz Auhmani Morocco 19 737 2.0× 247 1.2× 169 1.1× 95 1.0× 85 0.9× 83 1.1k
Yasameen K. Al-Majedy Iraq 13 402 1.1× 173 0.8× 88 0.6× 40 0.4× 48 0.5× 29 722
Mohamed S. Mohamed Ahmed Egypt 17 640 1.7× 172 0.8× 90 0.6× 45 0.5× 58 0.6× 41 980
El Mostapha Rakib Morocco 14 526 1.4× 94 0.5× 38 0.3× 19 0.2× 27 0.3× 89 800
Olabisi Theresa Ademosun Nigeria 9 162 0.4× 104 0.5× 44 0.3× 14 0.2× 36 0.4× 15 421
Maria Aparecida M. Maciel Brazil 12 124 0.3× 285 1.4× 229 1.5× 23 0.2× 157 1.7× 24 715
Muhammad Zubair Pakistan 15 278 0.7× 46 0.2× 15 0.1× 21 0.2× 11 0.1× 35 521
Sasidhar B. Somappa India 17 625 1.7× 111 0.5× 22 0.1× 31 0.3× 5 0.1× 43 939
Lucilene Dornelles Mello Brazil 10 60 0.2× 106 0.5× 34 0.2× 16 0.2× 29 0.3× 20 957
Abdelkrim Cheriti Algeria 14 95 0.3× 43 0.2× 17 0.1× 17 0.2× 13 0.1× 86 669

Countries citing papers authored by Farid Abrigach

Since Specialization
Citations

This map shows the geographic impact of Farid Abrigach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Abrigach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Abrigach more than expected).

Fields of papers citing papers by Farid Abrigach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Abrigach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Abrigach. The network helps show where Farid Abrigach may publish in the future.

Co-authorship network of co-authors of Farid Abrigach

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Abrigach. A scholar is included among the top collaborators of Farid Abrigach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Abrigach. Farid Abrigach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Loukili, El Hassania, Mohamed Bouhrim, Farid Abrigach, et al.. (2022). Chemical Composition, Antibacterial, Antifungal and Antidiabetic Activities of Ethanolic Extracts of Opuntia dillenii Fruits Collected from Morocco. Journal of Food Quality. 2022. 1–15. 33 indexed citations
4.
Kaddouri, Yassine, Farid Abrigach, Mohamed El Kodadi, et al.. (2022). New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals. 15(7). 803–803. 6 indexed citations
5.
Mohamed, Mounir A. A., et al.. (2022). Pyrazole, imidazole and triazole: In silico, docking and ADMET studies against SARS-CoV-2. Materials Today Proceedings. 72. 3686–3695. 1 indexed citations
6.
Dalli, Mohammed, Nour Elhouda Daoudi, Farid Abrigach, et al.. (2022). In vitro α-amylase and hemoglobin glycation inhibitory potential of Nigella sativa essential oil, and molecular docking studies of its principal components. Frontiers in Pharmacology. 13. 1036129–1036129. 14 indexed citations
7.
Loukili, El Hassania, et al.. (2021). Chemical Composition and Physicochemical Analysis of Opuntia dillenii Extracts Grown in Morocco. Journal of Chemistry. 2021. 1–11. 23 indexed citations
9.
Kaddouri, Yassine, Farid Abrigach, Belkheir Hammouti, et al.. (2020). New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems. Current Drug Delivery. 18(3). 334–349. 6 indexed citations
11.
Kaddouri, Yassine, et al.. (2020). New thiazole, pyridine and pyrazole derivatives as antioxidant candidates: synthesis, DFT calculations and molecular docking study. Heliyon. 6(1). e03185–e03185. 88 indexed citations
12.
Abrigach, Farid, Abdelilah Takfaoui, Pierre H. Dixneuf, et al.. (2019). Identification of novel antifungal agents: antimicrobial evaluation, SAR, ADME–Tox and molecular docking studies of a series of imidazole derivatives. BMC Chemistry. 13(1). 100–100. 23 indexed citations
13.
Abrigach, Farid, Yahya Rokni, Abdelilah Takfaoui, et al.. (2018). In vitro screening, homology modeling and molecular docking studies of some pyrazole and imidazole derivatives. Biomedicine & Pharmacotherapy. 103. 653–661. 66 indexed citations
15.
Abrigach, Farid, Olivier Riant, Yohan Macé, et al.. (2016). New N,N,N',N'-tetradentate Pyrazoly Agents: Synthesis and Evaluation of their Antifungal and Antibacterial Activities. Medicinal Chemistry. 12(1). 83–89. 24 indexed citations
16.
Abrigach, Farid & Rachid Touzani. (2016). Pyrazole Derivatives with NCN Junction and their Biological Activity: A Review. Medicinal Chemistry. 6(5). 28 indexed citations
17.
Abrigach, Farid, A. Bouyanzer, Rachid Touzani, et al.. (2015). Corrosion inhibition of mild steel by new N-heterocyclic compound in 1 M HCl: Experimental and computational study. Der pharma chemica. 7(8). 265–275. 56 indexed citations
18.
Abrigach, Farid, et al.. (2014). Antioxidant Activities of N-((3,5-dimethyl-1H-pyrazol-1-yl)methyl)pyridin-4- amine derivatives. Der pharma chemica. 6(3). 280–285. 3 indexed citations
19.
Abrigach, Farid, et al.. (2013). New nitrogen-donor pyrazole ligands for excellent liquid–liquid extraction of Fe2+ ions from aqueous solution, with theoretical study. Research on Chemical Intermediates. 41(6). 3319–3334. 16 indexed citations
20.
Saddik, Rafik, Farid Abrigach, N. Benchat, et al.. (2012). Catecholase activity investigation for pyridazinone- and thiopyridazinone-based ligands. Research on Chemical Intermediates. 38(8). 1987–1998. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026